Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Molecular mechanisms of bacterial invasion and colonization in the human gut microbiota

Project description

Bacterial invasion in the human gut

Multiple sclerosis (MS) is a debilitating neurological disorder that impacts approximately 2.8 million individuals globally, with 700 000 cases in Europe alone. Characterised by symptoms that can lead to chronic paralysis, MS poses significant challenges in monitoring and treatment. Current diagnostic methods primarily rely on subjective symptom evaluation and imaging techniques, which do not provide sufficient insight into the disease’s progression. There is a need for reliable biomarkers. Supported by the Marie Skłodowska-Curie Actions programme, the MonitorMS project explores cell-free chromatin found in plasma and cerebrospinal fluid as a potential biomarker for tracking MS pathology and treatment response. This approach will pave the way for improved diagnostics and personalised care in MS patients.

Objective

The human gut microbiota plays a critical role in safeguarding human health by defending against pathogens and supporting essential metabolic and immune functions. Nevertheless, our understanding of how the gut microbiota influences bacterial invasion and evolution within the human body is incomplete due to the complexity of these interactions. Furthermore, the specific mechanisms through which commensal bacteria, such as Escherichia coli, successfully invade and evolve in distinct human gut microbiota compositions remain unclear.
The MICROINVADER project aims to address this knowledge gap, utilizing an established in vitro gut simulator to investigate the precise mechanisms underlying the successful invasion of distinct human gut microbiota ecosystems by the commensal bacterium E. coli. Furthermore, MICROINVADER aims to characterize at the molecular level the processes that shape the evolution of invading strains in response to specific human gut microbiota compositions. Subsequently, MICROINVADER will validate these findings through in vitro and in vivo experiments, focusing on quantifying the selection strength acting on the genetic mechanisms that are crucial for bacterial invasion and colonization in different human gut environments.
By unveiling these novel mechanisms driving bacterial invasion and colonization within diverse human gut microbiotas, MICROINVADER seeks to provide critical insights that may have far-reaching implications for enhancing human health. Ultimately, MICROINVADER aims to contribute to our understanding of how to manipulate the gut microbiota in ways that promote and sustain overall well-being.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 195 914,88
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0